TriSalus Life Sciences Warrant
TLSIW
6 hedge funds and large institutions have $841K invested in TriSalus Life Sciences Warrant in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tower Research Capital (TRC)
New York
|
+$38 |
Top Sellers
TLSIW Hedge Fund Activity: Q3 2026 in Review
6 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2026, worth a combined $841K — up 5.3% from $798K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TLSIW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $38.
- 6 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2026, up from 5 in Q2 2026.
- Funds reported $841K of TriSalus Life Sciences Warrant stock for Q3 2026, up 5.3% quarter-over-quarter.
- 1 fund opened new TriSalus Life Sciences Warrant positions in Q3 2026 and 0 closed out, a net change of +1 holder.
- The largest TriSalus Life Sciences Warrant buyer in Q3 2026 was Tower Research Capital (TRC), an estimated $38 added.
Based on aggregated 13F filings for Q3 2026.